In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012–15 | Zendy

Krystyna M. Kazmierczak | Zendy; Boudewijn L. M. de Jonge | Zendy; Gregory G. Stone | Zendy; Daniel F. Sahm | Zendy

Open Access

In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012–15

Author(s) -

Krystyna M. Kazmierczak,

Boudewijn L. M. de Jonge,

Gregory G. Stone,

Daniel F. Sahm

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky266

Subject(s) - ceftazidime/avibactam , ceftazidime , avibactam , enterobacteriaceae , broth microdilution , colistin , microbiology and biotechnology , meropenem , carbapenem resistant enterobacteriaceae , biology , minimum inhibitory concentration , medicine , antimicrobial , antibiotic resistance , antibiotics , bacteria , escherichia coli , pseudomonas aeruginosa , gene , biochemistry , genetics

The activity of ceftazidime/avibactam was assessed against 24 750 isolates of Enterobacteriaceae collected from 96 medical centres in 18 European countries as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme from 2012 to 2015. Activity was analysed against subsets of isolates based on resistant phenotypes and β-lactamase content.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research